Pharma Test Introduces Next-Generation Tablet Dissolution Testing Instruments

Hainburg, Germany - Pharma Test is pleased to announce the upcoming launch of its next-generation tablet dissolution testing instruments, scheduled for release in the fourth quarter of 2025. The latest series features an enhanced user interface and a refined mechanical design.

With a modern graphical user interface, advanced user management features, and a fully integrated 21 CFR Part 11 compliant audit trail, the new systems set a new benchmark in usability and compliance. Building on decades of expertise and valuable customer feedback, Pharma Test has also introduced significant mechanical enhancements to ensure greater ease of use, improved reliability, and simplified maintenance, meeting the ever-growing needs of its customers. Made in Germany - all instruments are developed, designed, and manufactured in Germany.

“The introduction of our next-generation tablet dissolution tester marks an important milestone. Developed with user requirements in mind, these systems reflect our commitment to delivering user-oriented, robust, and sustainable solutions with long-term value for our customers,” declares Pharma Test CEO Björn Fähler on the upcoming launch.

The new models scheduled to launch in Q4/2025 are PTWS 830 with 8 stations, PTWS 1230 with 12 stations, and PTWS D630 with “Dual Drive” 6 + 6 stations.

About Pharma Test

Since 1979 Pharma Test has been a worldwide household name for the development and production of high-value test devices and systems for the quality control in the pharmaceutical, food and cosmetics industry as well as for universities and public authorities. We offer a complete product range from manual instruments for physical testing to fully automated online dissolution testing systems to analyze the active chemical composition of a dosage form as well as its release rate. Providing well thought-out, long- lasting, user-oriented products and solutions is our driving force. Made in Germany.